share_log

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

ELITE PHARMACEUTICALS INC | 8-K:Elite Pharmicals, Inc. 公布截至2024年9月30日的2025财年第二季度财务业绩,并提供电话会议信息
美股SEC公告 ·  2024/11/15 05:56

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。